Clinical Trial

A Prospective Study of Fortiva in Hernia Repair

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this study is to evaluate safety and performance of the Fortiva Tissue Matrix. Participants will complete questionnaires to measure outcomes after hernia surgery for two years.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-20; most recent amendment 2025-07-24.
Trial Details
NCT Number NCT06101979
Lead Sponsor RTI Surgical
Conditions Ventral Hernia, Incisional Hernia, Abdominal Wall Reconstruction
Enrollment 120 participants
Start Date 2023-11-15
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-07-25